to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Dr. Donald Francis is currently doing research to develop a vaccine for HIV at Genentech, Inc. In February of 1992 he retired after 20 years in the U.S. Public Health Service. At the time of his retirement he was the
Centers for Disease AIDS Advisor to the State of California and Special Consultant to Mayor Art Agnos in San Francisco. In the latter capacity he served as the Chair of the Mayor's HIV Task Force. Dr. Francis is a Californian having done
his undergraduate studies at the University of California at Berkeley. He received his M.D. from Northwestern University and his Doctor of Science from Harvard. Before beginning his work on AIDS, Dr. Francis was involved in epidemic
control around the world. He was instrumental in eradicating smallpox from Sudan, India and Bangladesh. He was also on the front line of the cholera epidemic in Nigeria in the early 1970's and the Ebola epidemic in Sudan in 1976. Dr.
Francis also did some of the early developmental work on the hepatitis B vaccine, both in the United States and in the People's Republic of China. He began his work on AIDS in 1981. He was one of the first scientists to suggest that AIDS
was caused by an infectious agent. As director of CDC's AIDS Laboratory Activities, he worked closely with the Institut Pasteur to prove that HIV was the cause of AIDS. He was also one of the earliest scientists to realize the impact HIV
would have on the United States and has been an indefatigable advocate for a logical public response.
ooma is the result of Andrew's desire to combine his technical expertise with his passion for innovative and fun consumer products. Andrew Co-founded his first technology company, an ISP in Las Vegas, at age 15. He then
joined Cisco as a full-time employee, and at 17 he became the youngest person ever to earn Cisco's top technical honor - a CCIE certification. He also earned a second one that same year, making him one of just eight people at the time to
do so. At age 19, he moved to Cisco's Global Center of Expertise to focus on critical networking issues for large service providers in the Pacific Rim and Latin America. After several years at Cisco, Andrew joined start-up core router
company Procket Networks as an engineer. He remained there until 2004, when he decided to return to his entrepreneurial roots as the founder of ooma. Andrew was recently named by the editors of Businessweek as one of the top entrepreneurs
under the age of 30 most likely to shape the world's digital future.
Juan Andrés Fontaine, Chile's Minister of Economy, Development and Tourism, discusses his government's recent practices and programs that strive to develop Chile's entrepreneurial ecosystem. Topics touched upon include government incentive programs to attract international investment, growth and development to Chile's university research and development, and a desire to build the nation into the innovation hub of South America.
Thomas J. Fogarty is a specialist whose creative talents have impacted many diverse professional and entrepreneurial arenas. In addition to his teaching responsibilities as Professor of Surgery at Stanford University,
Dr. Fogarty performs numerous cardiac and peripheral vascular surgeries, manages several medical device companies founded upon his product designs, is founder and active Senior Partner in the venture capital firm of Three Arch Partners,
and also finds time to pursue his interest in oenology at the family owned and operated Thomas Fogarty Winery and Vineyards. During the past 40 years he has acquired over 70 surgical patents, including the "industry standard" Fogarty
balloon embolectomy catheter. Patented in 1969, this first balloon catheter for the vascular system was a sophisticated version of the original crude instrument that young Tom Fogarty, then an OR scrub technician, designed in the late
1950's using a surgical glove finger tied to a ureteral catheter. Other commercially successful medical products designed by the Fogarty engineering group include a minimally invasive device for breast cancer diagnosis and therapy, and
also a self-expanding stent-graft used to treat critical aortic aneurysms via a minimally invasive technique. Dr. Fogarty is a past recipient of the Inventor of the Year award given by the San Francisco Patent and Trademark Association, a
four-time recipient of the Distinguished Scientific Presentation award presented by the American College of Surgeons, and was the first recipient to receive the award for "Achievement in Medicine" bestowed by the Santa Clara County Medical
Association. Selected recent awards include the 2000 Lemelson-MIT $500,000 Prize for Invention and Innovation as well as the Association for Advancement of Medical Instrumentation Foundation's Annual Laufman-Greatbatch Prize for inventing
breakthrough medical devices. Later in 200
Stephen P.A. Fodor is a native of Seattle, Washington. He received his B.S. in Biology and M.S. in Biochemistry from Washington State University and his Ph.D. in Chemistry at Princeton University. From 1986 to 1989, he
was a National Institutes of Health postdoctoral fellow at The University of California, Berkeley, working on time-resolved spectroscopy of bacterial and plant pigments. In 1989 he was recruited to the Affymax Research Institute in Palo
Alto where he spearheaded the effort to develop high-density arrays of biological compounds. Dr. Fodor and colleagues were the first to develop and describe microarray technologies and combinatorial chemistry synthesis. In 1993, Dr. Fodor
co-founded Affymetrix where the chip technology has been used to synthesize many varieties of high density oligonucleotide arrays containing hundreds of thousands of DNA probes. These DNA chips have broad commercial applications and are
now used in many areas of basic and clinical research including the detection of drug resistance mutations in infectious organisms, direct DNA sequence comparison of large segments of the human genome, the monitoring of multiple human
genes for cancer associated mutations, the quantitative and parallel measurement of mRNA expression for thousands of human genes, and the physical and genetic mapping of the human genome. In 2001, Dr. Fodor founded Perlegen, Inc., a new
venture that applied the chip technology on uncovering the basic patterns of human diversity. The adoption of the technology by both commercial and research institutions for these and other applications continues to grow
Founder, Chairman & CEO, JBoss Born in Paris in 1968, Marc got his Ph.D in physics from the Ecole Polytechnique in Paris. He started in Sales at Sun Microsystems France and then moved to the US where he worked on
early java enablement of SAP at SAPLabs. Marc started the JBoss project in 1999. An ex-Lieutenant in the paratroopers, Marc holds a degree in Mathematics from the Ecole Polytechnique, a master in Theoretical Physics from the Ecole Normale
ULM and was a visiting scientist at MIT during his thesis. Marc's research interest focuses on aspect oriented middleware.
Carleton S. (Carly) Fiorina was president and chief executive officer of Hewlett-Packard Company from 1999 to 2005. She served as chairman of the board from 2000 to 2005. Prior to joining HP, Fiorina spent nearly 20
years at AT&T and Lucent Technologies, where she held a number of senior leadership positions and directed Lucent's initial public offering and subsequent spin-off from AT&T. Fiorina was named an honorary fellow of the London
Business School in July 2001. In 2002, she was honored with the Appeal of Conscience Award, and in 2003 she received the Concern Worldwide "Seeds of Hope" Award in recognition of her worldwide efforts to make global citizenship a priority
for business. The Private Sector Council honored Fiorina with its 2004 Leadership Award for her contributions to improving the business of government. Also in 2004, the White House appointed her to the U.S. Space Commission. Fiorina has a
bachelor's degree in medieval history and philosophy from Stanford University. She holds a master's degree in business administration from the Robert H. Smith School of Business at the University of Maryland at College Park, Md., and a
master of science degree from MIT's Sloan School.
Jesse Fink is a founding partner of MissionPoint Capital and President and CEO of Marshall Street Management. In 2004, MSM established MSM Capital Partners to manage its investment activities in the clean technology and
environmental finance sectors. Jesse was the COO of Walker Digital Inc. and Priceline.com and previously worked at Georgia-Pacific, Citicorp, and CUC International. Jesse received a B.S. in Resource Management from the State University of
New York's College of Environmental Science and Forestry and an MBA from Syracuse University's School of Management. In February of 2007, Jesse received the Cleantech Venture Network's "Leader of the Year" award.
Kauffman FastTrac presents FastTrac Entrepreneurship WordCloud.
Judy Estrin is CEO of JLABS, LLC, formerly known as Packet Design Management Company, LLC. She is the author of Closing the Innovation Gap, published in September, 2008. Prior to co-founding Packet Design, in May 2000,
Estrin was chief technology officer for Cisco Systems. Beginning in 1981 Estrin co-founded three other successful technology companies: Bridge Communications, Network Computing Devices, and Precept Software. In 1998 Cisco Systems acquired
Precept, and she became Cisco's chief technology officer until April 2000. Estrin has been named three times to Fortune Magazine's list of the 50 most powerful women in American business. She sits on the boards of directors of The Walt
Disney Company and FedEx Corporation as well as two private company boards - Packet Design, Inc. and Arch Rock. She also sits on the advisory councils of Stanford's School of Engineering and Stanford's Bio-X initiative. She holds a B.S.
degree in math and computer science from UCLA, and an M.S. in electrical engineering from Stanford University.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.